1	2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Oxidative	_	_	JJ	_	_	_	_	_
2	Modification	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	rRNA	_	_	NN	_	_	_	_	_


1	rRNA	_	_	NNP	_	_	_	_	_
2	constitutes	_	_	VBZ	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	structural	_	_	JJ	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	functional	_	_	JJ	_	_	_	_	_
7	core	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	ribosome	_	_	NN	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	ROS	_	_	NNPS	_	_	_	_	_
2	can	_	_	MD	_	_	_	_	_
3	affect	_	_	VB	_	_	_	_	_
4	RNA	_	_	NN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	multitude	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	ways	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	including	_	_	VBG	_	_	_	_	_
12	chemical	_	_	JJ	_	_	_	_	_
13	modification	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	base	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	sugar	_	_	NN	_	_	_	_	_
19	moieties	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	generation	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	abasic	_	_	JJ	_	_	_	_	_
24	sites	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	strand	_	_	NN	_	_	_	_	_
28	breaks	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Guanine	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	most	_	_	RBS	_	_	_	_	_
5	easily	_	_	RB	_	_	_	_	_
6	oxidized	_	_	VBN	_	_	_	_	_
7	nucleobase	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	best	_	_	RBS	_	_	_	_	_
10	studied	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	this	_	_	DT	_	_	_	_	_
13	respect	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	oxidized	_	_	VBN	_	_	_	_	_
3	form	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	guanine	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	8-oxo-7,8-dihydroguanine	_	_	NN	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	8-hydroxyguanine	_	_	NN	_	_	_	_	_
10	;	_	_	:	_	_	_	_	_
11	8-oxo-G	_	_	NNP	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	ubiquitous	_	_	JJ	_	_	_	_	_
17	oxidative	_	_	JJ	_	_	_	_	_
18	lesion	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	readily	_	_	RB	_	_	_	_	_
21	detectable	_	_	JJ	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	cellular	_	_	JJ	_	_	_	_	_
24	nucleic	_	_	JJ	_	_	_	_	_
25	acids	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	When	_	_	WRB	_	_	_	_	_
2	present	_	_	JJ	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	mRNA	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	8-oxo-G	_	_	NN	_	_	_	_	_
7	interferes	_	_	VBZ	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	decoding	_	_	VBG	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	possibly	_	_	RB	_	_	_	_	_
12	through	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	formation	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	Hoogsteen	_	_	NNP	_	_	_	_	_
18	pair	_	_	NN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	adenine	_	_	NN	_	_	_	_	_
21	when	_	_	WRB	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	base	_	_	NN	_	_	_	_	_
24	rotates	_	_	VBZ	_	_	_	_	_
25	around	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	N-glycosidic	_	_	NNP	_	_	_	_	_
28	bond	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	altered	_	_	VBN	_	_	_	_	_
3	base-pairing	_	_	NN	_	_	_	_	_
4	capacity	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	8-oxo-G	_	_	NNP	_	_	_	_	_
7	can	_	_	MD	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	perturb	_	_	VB	_	_	_	_	_
10	RNA	_	_	NN	_	_	_	_	_
11	folding	_	_	VBG	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	recent	_	_	JJ	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	revealed	_	_	VBD	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	variety	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	outcomes	_	_	NNS	_	_	_	_	_
9	when	_	_	WRB	_	_	_	_	_
10	8-oxo-G	_	_	NNP	_	_	_	_	_
11	was	_	_	VBD	_	_	_	_	_
12	incorporated	_	_	VBN	_	_	_	_	_
13	into	_	_	IN	_	_	_	_	_
14	model	_	_	NN	_	_	_	_	_
15	RNA	_	_	NN	_	_	_	_	_
16	substrates	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	from	_	_	IN	_	_	_	_	_
19	stabilization	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	existing	_	_	VBG	_	_	_	_	_
22	structural	_	_	JJ	_	_	_	_	_
23	motifs	_	_	NNS	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	their	_	_	PRP$	_	_	_	_	_
26	destabilization	_	_	NN	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	rearrangements	_	_	NNS	_	_	_	_	_
29	into	_	_	IN	_	_	_	_	_
30	new	_	_	JJ	_	_	_	_	_
31	structures	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Since	_	_	IN	_	_	_	_	_
2	ribosome	_	_	NN	_	_	_	_	_
3	activities	_	_	NNS	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	translation	_	_	NN	_	_	_	_	_
6	depend	_	_	VBP	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	many	_	_	JJ	_	_	_	_	_
9	precisely	_	_	RB	_	_	_	_	_
10	tuned	_	_	VBN	_	_	_	_	_
11	conformational	_	_	JJ	_	_	_	_	_
12	changes	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	movements	_	_	NNS	_	_	_	_	_
15	within	_	_	IN	_	_	_	_	_
16	its	_	_	PRP$	_	_	_	_	_
17	rRNA	_	_	NN	_	_	_	_	_
18	framework	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	oxidation	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	bases	_	_	NNS	_	_	_	_	_
24	that	_	_	WDT	_	_	_	_	_
25	are	_	_	VBP	_	_	_	_	_
26	critical	_	_	JJ	_	_	_	_	_
27	for	_	_	IN	_	_	_	_	_
28	maintaining	_	_	VBG	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	correct	_	_	JJ	_	_	_	_	_
31	rRNA	_	_	NN	_	_	_	_	_
32	structure	_	_	NN	_	_	_	_	_
33	may	_	_	MD	_	_	_	_	_
34	impair	_	_	VB	_	_	_	_	_
35	ribosome	_	_	NN	_	_	_	_	_
36	functions	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	seems	_	_	VBZ	_	_	_	_	_
3	therefore	_	_	RB	_	_	_	_	_
4	likely	_	_	JJ	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	need	_	_	NN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	withstand	_	_	VB	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	certain	_	_	JJ	_	_	_	_	_
12	degree	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	oxidation	_	_	NN	_	_	_	_	_
15	was	_	_	VBD	_	_	_	_	_
16	one	_	_	CD	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	forces	_	_	NNS	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	shaping	_	_	VBG	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	evolution	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	ribosome	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	striking	_	_	JJ	_	_	_	_	_
3	disappearance	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	many	_	_	JJ	_	_	_	_	_
6	guanines	_	_	NNS	_	_	_	_	_
7	from	_	_	IN	_	_	_	_	_
8	mitochondrial	_	_	JJ	_	_	_	_	_
9	rRNA	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	reduced	_	_	VBN	_	_	_	_	_
12	overall	_	_	JJ	_	_	_	_	_
13	RNA	_	_	NN	_	_	_	_	_
14	content	_	_	NN	_	_	_	_	_
15	may	_	_	MD	_	_	_	_	_
16	be	_	_	VB	_	_	_	_	_
17	two	_	_	CD	_	_	_	_	_
18	such	_	_	JJ	_	_	_	_	_
19	evolutionary	_	_	JJ	_	_	_	_	_
20	adaptations	_	_	NNS	_	_	_	_	_
21	that	_	_	WDT	_	_	_	_	_
22	“	_	_	``	_	_	_	_	_
23	hardened	_	_	VBD	_	_	_	_	_
24	”	_	_	''	_	_	_	_	_
25	mitoribosomes	_	_	NNS	_	_	_	_	_
26	against	_	_	IN	_	_	_	_	_
27	damage	_	_	NN	_	_	_	_	_
28	from	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	abundant	_	_	JJ	_	_	_	_	_
31	ROS	_	_	NNPS	_	_	_	_	_
32	generated	_	_	VBN	_	_	_	_	_
33	inside	_	_	IN	_	_	_	_	_
34	mitochondria	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	extent	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	cellular	_	_	JJ	_	_	_	_	_
5	RNA	_	_	NN	_	_	_	_	_
6	oxidation	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	reported	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	exceed	_	_	VB	_	_	_	_	_
11	that	_	_	DT	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	DNA	_	_	NNP	_	_	_	_	_
14	when	_	_	WRB	_	_	_	_	_
15	cells	_	_	NNS	_	_	_	_	_
16	were	_	_	VBD	_	_	_	_	_
17	directly	_	_	RB	_	_	_	_	_
18	treated	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	H2O2	_	_	NN	_	_	_	_	_
21	or	_	_	CC	_	_	_	_	_
22	subjected	_	_	VBN	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	conditions	_	_	NNS	_	_	_	_	_
25	that	_	_	WDT	_	_	_	_	_
26	induce	_	_	VBP	_	_	_	_	_
27	secondary	_	_	JJ	_	_	_	_	_
28	oxidative	_	_	JJ	_	_	_	_	_
29	damage	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	such	_	_	JJ	_	_	_	_	_
32	as	_	_	IN	_	_	_	_	_
33	UVA	_	_	NN	_	_	_	_	_
34	irradiation	_	_	NN	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	ammonia	_	_	NN	_	_	_	_	_
37	overload	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	one	_	_	CD	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	exposure	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	E.	_	_	NNP	_	_	_	_	_
8	coli	_	_	NN	_	_	_	_	_
9	cells	_	_	NNS	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	H2O2	_	_	NNP	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	shown	_	_	VBN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	induce	_	_	VB	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	dosage-dependent	_	_	JJ	_	_	_	_	_
18	increase	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	8-oxo-G	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	all	_	_	DT	_	_	_	_	_
23	tested	_	_	VBN	_	_	_	_	_
24	RNA	_	_	NN	_	_	_	_	_
25	types	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	including	_	_	VBG	_	_	_	_	_
28	rRNA	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	By	_	_	IN	_	_	_	_	_
2	comparing	_	_	VBG	_	_	_	_	_
3	8-oxo-G	_	_	NN	_	_	_	_	_
4	levels	_	_	NNS	_	_	_	_	_
5	after	_	_	IN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	vitro	_	_	FW	_	_	_	_	_
8	H2O2	_	_	NN	_	_	_	_	_
9	treatment	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	RNAs	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	their	_	_	PRP$	_	_	_	_	_
14	native	_	_	JJ	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	denatured	_	_	JJ	_	_	_	_	_
17	forms	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	same	_	_	JJ	_	_	_	_	_
21	study	_	_	NN	_	_	_	_	_
22	concluded	_	_	VBD	_	_	_	_	_
23	that	_	_	IN	_	_	_	_	_
24	folding	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	rRNA	_	_	NN	_	_	_	_	_
27	did	_	_	VBD	_	_	_	_	_
28	not	_	_	RB	_	_	_	_	_
29	protect	_	_	VB	_	_	_	_	_
30	it	_	_	PRP	_	_	_	_	_
31	against	_	_	IN	_	_	_	_	_
32	oxidative	_	_	JJ	_	_	_	_	_
33	damage	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Similar	_	_	JJ	_	_	_	_	_
2	conclusions	_	_	NNS	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	made	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	Willi	_	_	NNP	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	colleagues	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	who	_	_	WP	_	_	_	_	_
11	used	_	_	VBD	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	8-oxo-G	_	_	NNP	_	_	_	_	_
14	antibody	_	_	NN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	immunoprecipitate	_	_	VB	_	_	_	_	_
17	oxidized	_	_	VBN	_	_	_	_	_
18	RNA	_	_	NN	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	H2O2-treated	_	_	JJ	_	_	_	_	_
21	E.	_	_	NNP	_	_	_	_	_
22	coli	_	_	NN	_	_	_	_	_
23	cells	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	large	_	_	JJ	_	_	_	_	_
3	body	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	observations	_	_	NNS	_	_	_	_	_
6	points	_	_	VBZ	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	association	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	oxidized	_	_	VBN	_	_	_	_	_
12	RNA	_	_	NN	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	disease	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	High	_	_	JJ	_	_	_	_	_
2	8-oxo-G	_	_	NN	_	_	_	_	_
3	content	_	_	NN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	cytoplasmic	_	_	JJ	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	nucleolar	_	_	JJ	_	_	_	_	_
8	RNA	_	_	NN	_	_	_	_	_
9	was	_	_	VBD	_	_	_	_	_
10	found	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	vulnerable	_	_	JJ	_	_	_	_	_
13	neurons	_	_	NNS	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	Alzheimer′s	_	_	NNP	_	_	_	_	_
16	disease	_	_	NN	_	_	_	_	_
17	(	_	_	-LRB-	_	_	_	_	_
18	AD	_	_	NNP	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	Parkinson	_	_	NNP	_	_	_	_	_
22	’s	_	_	POS	_	_	_	_	_
23	disease	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	neurons	_	_	NNS	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	hippocampal	_	_	JJ	_	_	_	_	_
30	region	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	temporal	_	_	JJ	_	_	_	_	_
33	neocortex	_	_	NN	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	patients	_	_	NNS	_	_	_	_	_
36	with	_	_	IN	_	_	_	_	_
37	Lewy	_	_	NNP	_	_	_	_	_
38	body	_	_	NN	_	_	_	_	_
39	dementia	_	_	NN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Elevated	_	_	VBN	_	_	_	_	_
2	levels	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	8-oxo-G	_	_	NN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	RNA	_	_	NN	_	_	_	_	_
7	were	_	_	VBD	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	detected	_	_	VBN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	neuropsychiatric	_	_	JJ	_	_	_	_	_
12	disorders	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	including	_	_	VBG	_	_	_	_	_
15	schizophrenia	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	depressive	_	_	JJ	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	bipolar	_	_	JJ	_	_	_	_	_
21	disorders	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Furthermore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	RNA	_	_	NNP	_	_	_	_	_
4	extracted	_	_	VBN	_	_	_	_	_
5	from	_	_	IN	_	_	_	_	_
6	atherosclerotic	_	_	JJ	_	_	_	_	_
7	plaques	_	_	NNS	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	heavily	_	_	RB	_	_	_	_	_
10	modified	_	_	VBN	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	8-oxo-G	_	_	NNP	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	links	_	_	NNS	_	_	_	_	_
3	between	_	_	IN	_	_	_	_	_
4	8-oxo-G	_	_	NNP	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	human	_	_	JJ	_	_	_	_	_
7	pathologies	_	_	NNS	_	_	_	_	_
8	have	_	_	VBP	_	_	_	_	_
9	been	_	_	VBN	_	_	_	_	_
10	based	_	_	VBN	_	_	_	_	_
11	largely	_	_	RB	_	_	_	_	_
12	on	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	analysis	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	total	_	_	JJ	_	_	_	_	_
17	RNA	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	rRNA	_	_	NNP	_	_	_	_	_
20	is	_	_	VBZ	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	most	_	_	RBS	_	_	_	_	_
23	abundant	_	_	JJ	_	_	_	_	_
24	cellular	_	_	JJ	_	_	_	_	_
25	RNA	_	_	NN	_	_	_	_	_
26	type	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	which	_	_	WDT	_	_	_	_	_
29	typically	_	_	RB	_	_	_	_	_
30	accounts	_	_	VBZ	_	_	_	_	_
31	for	_	_	IN	_	_	_	_	_
32	about	_	_	RB	_	_	_	_	_
33	80	_	_	CD	_	_	_	_	_
34	%	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	total	_	_	JJ	_	_	_	_	_
38	RNA	_	_	NN	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	from	_	_	IN	_	_	_	_	_
41	which	_	_	WDT	_	_	_	_	_
42	one	_	_	NN	_	_	_	_	_
43	can	_	_	MD	_	_	_	_	_
44	reasonably	_	_	RB	_	_	_	_	_
45	assume	_	_	VB	_	_	_	_	_
46	that	_	_	IN	_	_	_	_	_
47	oxidative	_	_	JJ	_	_	_	_	_
48	damage	_	_	NN	_	_	_	_	_
49	to	_	_	TO	_	_	_	_	_
50	ribosomes	_	_	NNS	_	_	_	_	_
51	in	_	_	IN	_	_	_	_	_
52	all	_	_	PDT	_	_	_	_	_
53	these	_	_	DT	_	_	_	_	_
54	pathological	_	_	JJ	_	_	_	_	_
55	conditions	_	_	NNS	_	_	_	_	_
56	must	_	_	MD	_	_	_	_	_
57	be	_	_	VB	_	_	_	_	_
58	widespread	_	_	JJ	_	_	_	_	_
59	.	_	_	.	_	_	_	_	_


1	Studies	_	_	NNS	_	_	_	_	_
2	that	_	_	WDT	_	_	_	_	_
3	focused	_	_	VBD	_	_	_	_	_
4	specifically	_	_	RB	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	rRNA	_	_	NNP	_	_	_	_	_
7	confirmed	_	_	VBD	_	_	_	_	_
8	it	_	_	PRP	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	be	_	_	VB	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	major	_	_	JJ	_	_	_	_	_
13	target	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	8-oxo-G	_	_	NN	_	_	_	_	_
17	modification	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	patients	_	_	NNS	_	_	_	_	_
20	with	_	_	IN	_	_	_	_	_
21	AD	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	mild	_	_	JJ	_	_	_	_	_
24	cognitive	_	_	JJ	_	_	_	_	_
25	impairment	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	condition	_	_	NN	_	_	_	_	_
29	that	_	_	WDT	_	_	_	_	_
30	often	_	_	RB	_	_	_	_	_
31	precedes	_	_	VBZ	_	_	_	_	_
32	AD	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_

